Tolvaptan

Brand name: Jynarque

Rank #320 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$34.4M

Total Cost

Share:

2,760

Total Claims

$34.4M

Total Cost

174

Prescribers

$12K

Cost per Claim

0

Beneficiaries

2,891

30-Day Fills

$197K

Avg Cost/Provider

16

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$34.4M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $34.4M total

🔎 Data Overview

💰

At $12,447 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $197,438 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Tolvaptan

#ProviderSpecialtyLocationClaimsCost
1James EvansonNephrologyEvansville, IN38$707K
2Michael BrucculeriNephrologyClearwater, FL47$593K
3Osama AmroNephrologySeattle, WA30$556K
4Arzu HatipogluNephrologyChalmette, LA28$522K
5Alexander ChangNephrologyDanville, PA27$506K
6Mamoon RasheedNephrologyOklahoma City, OK26$503K
7John MorrisNephrologyMemphis, TN26$488K
8Douglas LaxNephrologyRockville Centre, NY35$469K
9Michael FangInternal MedicineDowney, CA25$458K
10Imran DosaniNephrologyMadisonville, KY24$442K
11Gurmukteshwar SinghNephrologyDanville, PA24$438K
12Abeera MansurNephrologyGarden City, KS23$433K
13Imtiaz IslamNephrologyKearney, NE22$418K
14Anthony TranNephrologyMelbourne, FL21$398K
15Paula Duran SierraNephrologyTemple, TX22$364K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
317Trametinib Dimethyl Sulfoxide (Mekinist)$35.0M2,448
318Isosorbide Mononitrate (Isosorbide Mononitrate Er)$34.5M1,805,114
319Clonazepam (Clonazepam)$34.4M3,685,968
320Tolvaptan (Jynarque)$34.4M2,760
321Dalfampridine (Dalfampridine Er)$34.1M40,425
322Olmesartan Medoxomil (Olmesartan Medoxomil)$33.8M1,102,412
323Niraparib Tosylate (Zejula)$33.7M2,206

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology